SCARTOZZI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.724
AS - Asia 1.775
EU - Europa 1.333
SA - Sud America 283
AF - Africa 41
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.656
SG - Singapore 633
GB - Regno Unito 356
CN - Cina 298
VN - Vietnam 232
HK - Hong Kong 219
BR - Brasile 216
IT - Italia 202
FI - Finlandia 185
DE - Germania 166
SE - Svezia 139
BD - Bangladesh 138
FR - Francia 74
RU - Federazione Russa 73
TR - Turchia 66
ID - Indonesia 39
BG - Bulgaria 31
IN - India 30
CA - Canada 29
JP - Giappone 25
AR - Argentina 24
UA - Ucraina 19
IQ - Iraq 18
NL - Olanda 17
IE - Irlanda 14
VE - Venezuela 14
MX - Messico 11
PK - Pakistan 10
ZA - Sudafrica 10
EG - Egitto 9
AT - Austria 8
KR - Corea 8
SA - Arabia Saudita 7
BE - Belgio 6
CO - Colombia 6
JM - Giamaica 6
CH - Svizzera 5
CL - Cile 5
EC - Ecuador 5
JO - Giordania 5
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
PH - Filippine 5
RO - Romania 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
BZ - Belize 4
CR - Costa Rica 4
IL - Israele 4
LT - Lituania 4
LU - Lussemburgo 4
NO - Norvegia 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GT - Guatemala 3
KE - Kenya 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ES - Italia 2
HN - Honduras 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
IR - Iran 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
ML - Mali 1
MQ - Martinica 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
Totale 8.158
Salva come PNG Salva come JPEG
Città #
Fairfield 712
Ashburn 536
Santa Clara 415
Singapore 406
Seattle 304
Woodbridge 292
Chandler 251
Houston 248
Wilmington 219
Cambridge 218
Hong Kong 216
Southend 210
Helsinki 174
San Jose 150
Dearborn 117
Nyköping 106
London 98
Ann Arbor 74
Council Bluffs 68
New York 67
Beijing 61
Izmir 58
Ho Chi Minh City 55
Hanoi 50
San Diego 47
Dong Ket 44
The Dalles 40
Lauterbourg 38
Los Angeles 35
Jakarta 34
Munich 32
Milan 31
Princeton 31
Sofia 31
Bremen 30
Eugene 30
Phoenix 30
Shanghai 26
Orem 24
São Paulo 24
Chicago 22
Tokyo 22
Modena 20
Buffalo 18
Redondo Beach 15
Dallas 14
Boardman 12
Dublin 12
Falkenstein 10
Jacksonville 10
Frankfurt am Main 9
Turku 9
Atlanta 8
Cairo 8
Hefei 8
Montreal 8
Portsmouth 8
Chennai 7
Da Nang 7
Haiphong 7
Kunming 7
Miano 7
Moscow 7
Norwalk 7
Salt Lake City 7
Seoul 7
Toronto 7
Baghdad 6
Columbus 6
Curitiba 6
Denver 6
Guangzhou 6
Hanover 6
Naples 6
Rio de Janeiro 6
Salvador 6
Turin 6
Amsterdam 5
Brooklyn 5
Charlotte 5
Criciúma 5
Jieyang 5
Mumbai 5
Amman 4
Baku 4
Belize City 4
Brussels 4
Dhaka 4
Düsseldorf 4
Edinburgh 4
Hounslow 4
Jinan 4
Johannesburg 4
Lahore 4
Lima 4
Nanjing 4
Nuremberg 4
Redwood City 4
Ribeirão Preto 4
Rome 4
Totale 6.073
Salva come PNG Salva come JPEG
Nome #
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 356
Immunotherapy for colorectal cancer: where are we heading? 336
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 316
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients 315
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) 313
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 305
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma 298
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial 289
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale 283
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 281
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 276
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 274
Immunotherapeutic approaches for hepatocellular carcinoma 274
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 271
The Italian Rare Pancreatic Exocrine Cancer Initiative 267
Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report 264
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib 255
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 253
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 250
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC) 250
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 247
Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study 246
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer 245
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 241
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 238
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 227
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 226
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 221
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 217
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? 183
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 133
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 112
Totale 8.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.306
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022628 80 22 23 36 15 45 13 49 62 76 129 78
2022/2023727 87 80 40 59 105 80 16 75 86 9 46 44
2023/2024288 9 16 10 45 65 2 33 40 3 7 8 50
2024/20251.399 39 24 5 116 286 229 141 84 190 45 75 165
2025/20262.254 125 47 97 179 366 159 310 83 227 212 246 203
2026/202768 68 0 0 0 0 0 0 0 0 0 0 0
Totale 8.262